TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20

TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20

<p><strong>Objectives</strong></p> <p>About half of RA patients treated with TNFα inhibitors either do not respond or lose their initial therapeutic response over time. The clinical response is measured by reduction in DAS28, which primarily reflects inflammation. Howev...

書誌詳細
主要な著者:	Al-Bogami, M, Bystrom, J, Clanchy, F, Taher, TE, Mangat, P, Williams, RO, Jawad, AS, Mageed, RA
フォーマット:	Journal article
言語:	English
出版事項:	Oxford University Press 2020

類似資料

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
著者:: Bystrom, J, 等
出版事項: (2017)

TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
著者:: Bystrom, J, 等
出版事項: (2016)

Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
著者:: Clanchy, FIL, 等
出版事項: (2022)

TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
著者:: Clanchy, FIL, 等
出版事項: (2021)

Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
著者:: Taylor, PC, 等
出版事項: (2024)

New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis
著者:: Emilie Hascoët, 等
出版事項: (2023-05-01)

Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions
著者:: H. Allard-Chamard, 等
出版事項: (2020-06-01)

Harnessing the Therapeutic Potential of Th17 Cells.
著者:: Bystrom, J, 等
出版事項: (2015)

Osteoclast differentiation in rheumatoid arthritis
著者:: Kazuhiro Yokota
出版事項: (2024-01-01)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
著者:: Delphine Dénarié, 等
出版事項: (2017-01-01)

Functional and phenotypic heterogeneity of Th17 cells in health and disease
著者:: Bystrom, J, 等
出版事項: (2018)

Pathological Osteoclasts and Precursor Macrophages in Inflammatory Arthritis
著者:: Tetsuo Hasegawa, 等
出版事項: (2022-04-01)

Lymphocytes: precursor frequencies
著者:: Clanchy, F, 等
出版事項: (2017)

Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.
著者:: Marieke M J Herenius, 等
出版事項: (2013-01-01)

Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
著者:: Qing Niu, 等
出版事項: (2022-11-01)

Harnessing the Therapeutic Potential of Th17 Cells
著者:: Jonas Bystrom, 等
出版事項: (2015-01-01)

Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
著者:: Hirayama, T, 等
出版事項: (2002)

The role of osteoclast formation in the pathogenesis of osteoporosis in rheumatoid arthritis
著者:: Hirayama, T, 等
出版事項: (2001)

The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings
著者:: Naoki Iwamoto, 等
出版事項: (2022-09-01)

CD14+CD16− monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK
著者:: Jimeng Xue, 等
出版事項: (2020-09-01)

20th anniversary of TNF inhibitors in rheumatoid arthritis
著者:: Taylor, P
出版事項: (2019)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
著者:: Feldmann, M, 等
出版事項: (2011)

Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.
著者:: Yu Xue, 等
出版事項: (2012-01-01)

Cellular mechanisms of osteoclast formation and bone resorption in rheumatoid arthritis
著者:: Danks, L, 等
出版事項: (2001)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
著者:: Maini, R, 等
出版事項: (1993)

Th17 Lymphocytes in Respiratory Syncytial Virus Infection
著者:: Rizgar A. Mageed, 等
出版事項: (2013-03-01)

Mir-342-3p regulates ostoclastogenesis in arthritis-associated osteoclast precursors
著者:: Claire Lozano, 等
出版事項: (2020-10-01)

Development of anti-TNF therapy for rheumatoid arthritis.
著者:: Feldmann, M
出版事項: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
著者:: Maini, R, 等
出版事項: (1994)

Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2hi Osteoclast Progenitors to the Affected Bone
著者:: Darja Flegar, 等
出版事項: (2021-12-01)

The role of light in osteoclast formation and pathological bone resorption in rheumatoid arthritis
著者:: Athanasou, NA, 等
出版事項: (2017)

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent.
著者:: Itonaga, I, 等
出版事項: (2000)

Osteoclast microRNA Profiling in Rheumatoid Arthritis to Capture the Erosive Factor
著者:: Nguyen Hoang Dong, 等
出版事項: (2023-08-01)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
著者:: Ulrike Steffen, 等
出版事項: (2019-07-01)

The number of CD14+osteoclast precursors in acute charcot patients is correlated to the serum levels of tnf-alpha
著者:: Mabilleau, G, 等
出版事項: (2009)

Regulation of TNF-Induced Osteoclast Differentiation
著者:: Zhenqiang Yao, 等
出版事項: (2021-12-01)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
著者:: E. A. Golikova, 等
出版事項: (2012-05-01)

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
著者:: Elden Aake, 等
出版事項: (2011-02-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
著者:: Hisakata Yamada, 等
出版事項: (2020-04-01)

Reduced skeletal muscle independently predicts 1-year aggravated joint destruction in patients with rheumatoid arthritis
著者:: Jian-Zi Lin, 等
出版事項: (2020-08-01)